Establishment and characterization of an osteocyte-like cell line, MLO- Y4

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Much attention has focused on osteoblast and osteoclast biology, but little research has been performed on the cell that composes 90% of all bone cells - the osteocyte. Osteocyte function has been difficult to study because these cells are embedded in mineralized tissue and are difficult to obtain in reasonable numbers and purity. Establishment of an osteocyte cell line makes it possible to study osteocyte function more readily and easily by the application of protein chemistry and molecular biology. We have established a cell line that appears to have the properties of primary osteocytes [1]. The cell line is designated MLO-Y4 (for murine long-bone osteocyte) and was established from transgenic mice created using the osteocalcin promoter driving the large T antigen. This cell line, compared to osteoblasts, expresses long dendritic processes and produces small amounts of alkaline phosphatase and collagen type 1, large amounts of osteocalcin, and very large amounts of connexin 43, a gap junction protein, but similar amounts of osteopontin and CD44. Interestingly, this cell line does not express osteoblast-specific factor 2. This cell line also has functional gap junctions transmitting through the dendritic processes. On exposure to fluid flow, an increase in prostaglandin production occurs concomitant with a dramatic increase in functional gap junctions. Monoclonal antibodies have been generated using these cells, which appear to recognize osteocyte- specific antigens. This cell line and these antibodies should prove to be useful tools for examining osteocyte function.

Original languageEnglish (US)
Pages (from-to)61-65
Number of pages5
JournalJournal of Bone and Mineral Metabolism
Volume17
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Osteocytes
Cell Line
Osteoblasts
Gap Junctions
Osteocalcin
Bone and Bones
Connexin 43
Osteopontin
Connexins
Viral Tumor Antigens
Osteoclasts
Collagen Type I
Transgenic Mice
Prostaglandins
Alkaline Phosphatase
Molecular Biology
Monoclonal Antibodies
Antigens
Antibodies

ASJC Scopus subject areas

  • Endocrinology

Cite this

Establishment and characterization of an osteocyte-like cell line, MLO- Y4. / Bonewald, Lynda.

In: Journal of Bone and Mineral Metabolism, Vol. 17, No. 1, 1999, p. 61-65.

Research output: Contribution to journalArticle

@article{b9b2b0695e284e698d170ca2fc9391ee,
title = "Establishment and characterization of an osteocyte-like cell line, MLO- Y4",
abstract = "Much attention has focused on osteoblast and osteoclast biology, but little research has been performed on the cell that composes 90{\%} of all bone cells - the osteocyte. Osteocyte function has been difficult to study because these cells are embedded in mineralized tissue and are difficult to obtain in reasonable numbers and purity. Establishment of an osteocyte cell line makes it possible to study osteocyte function more readily and easily by the application of protein chemistry and molecular biology. We have established a cell line that appears to have the properties of primary osteocytes [1]. The cell line is designated MLO-Y4 (for murine long-bone osteocyte) and was established from transgenic mice created using the osteocalcin promoter driving the large T antigen. This cell line, compared to osteoblasts, expresses long dendritic processes and produces small amounts of alkaline phosphatase and collagen type 1, large amounts of osteocalcin, and very large amounts of connexin 43, a gap junction protein, but similar amounts of osteopontin and CD44. Interestingly, this cell line does not express osteoblast-specific factor 2. This cell line also has functional gap junctions transmitting through the dendritic processes. On exposure to fluid flow, an increase in prostaglandin production occurs concomitant with a dramatic increase in functional gap junctions. Monoclonal antibodies have been generated using these cells, which appear to recognize osteocyte- specific antigens. This cell line and these antibodies should prove to be useful tools for examining osteocyte function.",
author = "Lynda Bonewald",
year = "1999",
doi = "10.1007/s007740050066",
language = "English (US)",
volume = "17",
pages = "61--65",
journal = "Journal of Bone and Mineral Metabolism",
issn = "0910-0067",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Establishment and characterization of an osteocyte-like cell line, MLO- Y4

AU - Bonewald, Lynda

PY - 1999

Y1 - 1999

N2 - Much attention has focused on osteoblast and osteoclast biology, but little research has been performed on the cell that composes 90% of all bone cells - the osteocyte. Osteocyte function has been difficult to study because these cells are embedded in mineralized tissue and are difficult to obtain in reasonable numbers and purity. Establishment of an osteocyte cell line makes it possible to study osteocyte function more readily and easily by the application of protein chemistry and molecular biology. We have established a cell line that appears to have the properties of primary osteocytes [1]. The cell line is designated MLO-Y4 (for murine long-bone osteocyte) and was established from transgenic mice created using the osteocalcin promoter driving the large T antigen. This cell line, compared to osteoblasts, expresses long dendritic processes and produces small amounts of alkaline phosphatase and collagen type 1, large amounts of osteocalcin, and very large amounts of connexin 43, a gap junction protein, but similar amounts of osteopontin and CD44. Interestingly, this cell line does not express osteoblast-specific factor 2. This cell line also has functional gap junctions transmitting through the dendritic processes. On exposure to fluid flow, an increase in prostaglandin production occurs concomitant with a dramatic increase in functional gap junctions. Monoclonal antibodies have been generated using these cells, which appear to recognize osteocyte- specific antigens. This cell line and these antibodies should prove to be useful tools for examining osteocyte function.

AB - Much attention has focused on osteoblast and osteoclast biology, but little research has been performed on the cell that composes 90% of all bone cells - the osteocyte. Osteocyte function has been difficult to study because these cells are embedded in mineralized tissue and are difficult to obtain in reasonable numbers and purity. Establishment of an osteocyte cell line makes it possible to study osteocyte function more readily and easily by the application of protein chemistry and molecular biology. We have established a cell line that appears to have the properties of primary osteocytes [1]. The cell line is designated MLO-Y4 (for murine long-bone osteocyte) and was established from transgenic mice created using the osteocalcin promoter driving the large T antigen. This cell line, compared to osteoblasts, expresses long dendritic processes and produces small amounts of alkaline phosphatase and collagen type 1, large amounts of osteocalcin, and very large amounts of connexin 43, a gap junction protein, but similar amounts of osteopontin and CD44. Interestingly, this cell line does not express osteoblast-specific factor 2. This cell line also has functional gap junctions transmitting through the dendritic processes. On exposure to fluid flow, an increase in prostaglandin production occurs concomitant with a dramatic increase in functional gap junctions. Monoclonal antibodies have been generated using these cells, which appear to recognize osteocyte- specific antigens. This cell line and these antibodies should prove to be useful tools for examining osteocyte function.

UR - http://www.scopus.com/inward/record.url?scp=0033055990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033055990&partnerID=8YFLogxK

U2 - 10.1007/s007740050066

DO - 10.1007/s007740050066

M3 - Article

C2 - 10084404

AN - SCOPUS:0033055990

VL - 17

SP - 61

EP - 65

JO - Journal of Bone and Mineral Metabolism

JF - Journal of Bone and Mineral Metabolism

SN - 0910-0067

IS - 1

ER -